ARRAY BIOPHARMA INC. news, videos and press releases - Page 3
For more news please use our advanced search feature.
ARRAY BIOPHARMA INC. - More news...
ARRAY BIOPHARMA INC. - More news...
- SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Array Biopharma, Inc. (ARRY)
- Array BioPharma Announces Private Exchange of $107 Million of its 3.00% Convertible Senior Notes due 2020 for its 2.625% Convertible Senior Notes due 2024 and Shares of its Common Stock
- Array BioPharma Reports Initial Results From Novel Immunotherapy Combination At The Society For Immunotherapy Of Cancer (SITC) 32nd Annual Meeting
- Array BioPharma To Present At The 2017 Stifel Healthcare Conference
- Factors of Influence in 2018, Key Indicators and Opportunity within AGNC Investment, Discovery Communications, Array BioPharma, Callon Petroleum, People's United, and DDR – New Research Emphasizes Economic Growth
- Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2018
- Array BioPharma Inc. to Host Earnings Call
- Array Biopharma To Report Financial Results For The First Quarter Of Fiscal 2018 On October 31, 2017
- Array BioPharma To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference
- Array BioPharma Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
- Array BioPharma Announces Pricing of Public Offering of Common Stock
- Array BioPharma Announces Proposed Public Offering of Common Stock
- Array BioPharma Announces FDA Acceptance For Review Of Binimetinib And Encorafenib New Drug Applications For Patients With Advanced BRAF-mutant Melanoma
- Phase 3 COLUMBUS Part 2 Results in BRAF-Mutant Melanoma Presented at European Society for Medical Oncology Congress
- Phase 3 BEACON CRC Safety Lead-In Results in BRAF-Mutant Colorectal Cancer Presented at European Society for Medical Oncology Congress
- Array Biopharma To Present BEACON CRC Safety Lead-in And COLUMBUS Part 2 Results At European Society For Medical Oncology Congress (ESMO)
- Array BioPharma To Present At The 2017 Wells Fargo Healthcare Conference
- Array BioPharma Appoints Curtis Oltmans As General Counsel
- Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2017
- Investor Network: Array BioPharma Inc. to Host Earnings Call
- Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2017 On August 9, 2017
- Array BioPharma Submits New Drug Applications To FDA For Binimetinib And Encorafenib In Advanced Melanoma
- Array Biopharma To Present At The Goldman Sachs 38th Annual Global Healthcare Conference
- Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And Commercialization Partnership For Two Novel Oncology Compounds, Binimetinib And Encorafenib
- Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
- Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2017
- Investor Network: Array BioPharma Inc. to Host Earnings Call
- Array BioPharma Announces Positive Top-Line Results from Part 2 of the Phase 3 COLUMBUS Study of Binimetinib and Encorafenib for BRAF-Mutant Melanoma
- Array BioPharma Announces Strategic Collaboration with Merck
- Array Biopharma To Report Financial Results For The Third Quarter Of Fiscal 2017 On May 10, 2017
